In Brief

Solace International’s advertisements for DermaTend Mole Wart & Skin Tag Remover likely will face FTC scrutiny soon. The National Advertising Division of the Council of Better Business Bureaus referred the firm’s ads to FTC after Solace declined to participate in the self-regulatory review process. NAD requested substantiation for claims DermaTend Mole Wart & Skin Tag Remover “permanently removes all unwanted moles, warts and skin tags quickly and easily,” “is just as effective as surgery” and “unlike surgery, you won’t be left with unsightly scars and or a large doctor bill.” The firm denied misleading or improper advertising, but volunteered to remove references to surgery and doctor bills from the ads. Despite these changes, NAD says in a Nov. 8 release that it referred the firm to FTC because “such action did not resolve the remaining challenged claims.”

TriVita Inc. should “clearly and conspicuously” disclose when testimonials for Nopalea are made by company members who receive a commission for selling the supplement, the Electronic Retailing Self-Regulation Program determines....